<DOC>
	<DOCNO>NCT01057589</DOCNO>
	<brief_summary>The purpose trial estimate progression free survival patient recurrent metastatic head neck cancer receive chemotherapy setting .</brief_summary>
	<brief_title>A Study Patients With Recurrent Metastatic Squamous Cell Head Neck Cancer</brief_title>
	<detailed_description>A 12 patient safety lead evaluate side effect patient receive least 2 cycle combination pemetrexed , cisplatin cetuximab .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Histologically confirm diagnosis squamous cell carcinoma head neck ( SCCHN ) Recurrent metastatic SCCHN , amenable local therapy At least 6 month since completion systemic therapy ( chemotherapy biological anticancer therapy ) No 1 prior systemic therapy , give part multimodal treatment locally advanced disease ; No prior systemic therapy metastatic disease Radiation therapy must complete least 4 week study enrollment . For palliative therapy , prior radiation therapy allow &lt; 25 % bone marrow ( Cristy Eckerman 1987 ) , prior radiation whole pelvis allow . Surgery ( exclude prior diagnostic biopsy ) must complete least 4 week study enrollment . An estimated life expectancy least 12 week . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ( Oken et al . 1982 ) . Biological tissue available biomarker analysis tumor tissue . Disease status may measurable nonmeasurable define Response Evaluation Criteria Solid Tumors Patient compliance geographic proximity allow adequate followup . Adequate organ function Willingness comply Contraceptive Regimen For woman : Must surgically sterile , postmenopausal , compliant medically approve contraceptive regimen [ example , intrauterine device ( IUD ) , birth control pill , barrier device ] 6 month treatment period ; must negative serum urine pregnancy test within 7 day study enrollment , must breastfeed . For men : Must surgically sterile compliant contraceptive regimen 6 month treatment period . Nasopharyngeal , paranasal sinus , lip , salivary gland cancer . Previously receive treatment monoclonal antibody therapy , signal transduction inhibitor Epidermal Growth Factor Receptor therapy . Are receive concurrent chronic systemic immune therapy , chemotherapy disease cancer . Serious concomitant systemic disorder ( example , active infection ) psychiatric disorder , opinion investigator , would compromise patient 's ability complete study . Have serious cardiac disease , symptomatic , unstable angina , history myocardial infarction previous 12 month . Second primary malignancy clinically detectable time consideration study enrollment . Have another primary malignancy Head Neck cancer , unless prior malignancy treat least 2 year previously evidence recurrence . Exception : Patients history situ carcinoma cervix , nonmelanoma skin cancer , lowgrade ( Gleason score less equal 6 ) localize prostate cancer eligible even diagnose treat less 2 year previously . Presence clinically significant ( physical exam ) thirdspace fluid collection ; example , ascites pleural effusion control drainage procedure prior study entry . Have peripheral neuropathy Have central nervous system ( CNS ) metastases ( unless patient complete successful local therapy CNS metastases corticosteroid least 4 week start study therapy ) . Brain imaging require symptomatic patient rule brain metastasis , require asymptomatic patient . Inability interrupt aspirin nonsteroidal antiinflammatory agent , aspirin dose less equal 1.3 gram per day , 5day period ( 8day period longacting agent , piroxicam ) . Unable unwilling take folic acid , vitamin B12 , prophylactic corticosteroid . Recent ( within 30 day enrollment ) concurrent yellow fever vaccination . Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Pharynx</keyword>
	<keyword>Larynx</keyword>
	<keyword>Cervical esophagus</keyword>
	<keyword>Nose</keyword>
	<keyword>Thyroid Gland</keyword>
	<keyword>Parathyroid Gland</keyword>
</DOC>